Lowest Price Guaranteed
Pages
198
Last Updated
June 2025
View Count
5638
The global proton therapy systems market, valued at USD 1.49 billion in 2024, is projected to reach USD 1.66 billion in 2025 and USD 4.09 billion by 2035, representing a CAGR of 9.4% during the forecast period.
 |
To learn more about this report, request a free sample copy
Proton therapy is a form of radiotherapy that utilize high-energy protons to target and kill cancer cells precisely without damaging healthy tissues. The demand for proton therapy has significantly increased, driven by the rising incidence of cancer across the globe. According to the American Cancer Society Statistics, in 2025 around 2.04 million new cancer cases will be diagnosed and around 6,18,120 cancer deaths are projected to occur in the US.
In order to mitigate the growing concern of cancer worldwide, healthcare professionals are focusing on early diagnosis and precise cancer cell targeting treatment. Proton therapy systems in such instance emerged as a potential solution to delivery radiation at targeted site without affecting healthy tissues. Contrastingly, proton therapy offers several significances such as higher precision, less damage to healthy tissues and few side effects, such as low hair loss, which further is driving its adoption across healthcare professionals for cancer treatment.
A number of healthcare facilities are installing proton therapy systems. For instance, in June 2024, Atlantic Health System announced the plan to acquire and install a MEVION S250-FIT Proton Therapy System™ at a Carol G. Simon Cancer Center, at Morristown Medical Center in New Jersey. Furthermore, in December 2024, an anonymous donor gifted USD 50 million to Duke University Health System to develop proton beam therapy center to treat cancer patients.
Owing to the ongoing initiatives and expanding adoption of advanced therapies, it is expected that proton therapy systems market will continue to expand substantially during the forecast period.
The market report provides comprehensive information on proton therapy system manufacturers who are currently active across various segments of the industry as mentioned in the table below.
| Key Report Attributes | Details | |
| Historical Trend | Since 2020 | |
| Forecast Period | Till 2035 | |
| Market Size 2025 | USD 1.66 Billion | |
| Market Size 2035 | USD 4.09 Billion | |
| CAGR (Till 2035) | 9.4% | |
| Type of Product |
|
|
| Type of System |
|
|
| Type of Set-Up |
|
|
| Type of Indication |
|
|
| End User |
|
|
| Geographical Regions |
|
|
| Key Companies Profiled |
|
|
| PowerPoint Presentation (Complimentary) |
Available | |
| Customization Scope | 15% Free Customization | |
| Excel Data Packs (Complimentary) |
Available | |
One of the key objectives of the proton therapy systems market report was to estimate the current size, opportunity, and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.
The global proton therapy systems market analysis report also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of product (equipment and services), type of system (proton therapy systems with robotized positioning table, proton therapy systems with integrated CT scanner and proton therapy systems with integrated PET scanners), type of set up (single-room systems and multi-room systems), type of indication (breast cancer, lung cancer, prostate cancer, gastro-intestinal cancer, brain cancer and others), end user (hospitals, proton therapy centers and other end users), geographical regions (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.
In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three proton therapy systems market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.
All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.
Based on the type of product, the global market is segmented into equipment and services. According to our proton therapy systems market report, presently equipment holds 90% of the market share. This can be attributed to the widespread adoption of proton therapy systems and instruments in hospitals to treat patients.
However, in the long run, the services segment is expected to grow at a higher CAGR during the forecast period. This is likely to be the result of a growing shift towards proton therapy services providers to mitigate the growing concern of cancer.
On the basis of system type, the global market is categorized into proton therapy systems with robotized positioning table, proton therapy systems with integrated CT scanner and proton therapy systems with integrated PET scanners. According to our proton therapy systems market analysis, presently proton therapy systems with robotized positioning table segment dominate the market by holding 35% of overall revenue share. Proton therapy systems with robotized positioning table enhance accuracy during patient treatment as it allows automated adjustment of patient positioning for precise targeting of beam at localized site of cancer.
However, in the future, proton therapy systems with integrated CT scanner is expected to grow at a higher CAGR during the forecast period. This can be attributed to the increasing technological innovation to integrate advanced imaging solutions for the identification of tumor sites in patients with real-time imaging abilities.
The global market is further sub-divided based on the type of set-up into single-room systems and multi-room systems. According to our proton therapy systems market report, the multi-room systems segment holds 72% share of the market and the trend is unlikely to change in the future. Multi-room systems help to generate beams to be delivered to different rooms simultaneously to treat multiple patients at one time, thereby saving time for treatment cycle.
However, the single-room systems segment is expected to register a higher CAGR driven by the increasing demand for compact and low-cost solutions for treating patients.
This segment highlights the distribution of global market across different types of indication, such as breast cancer, lung cancer, prostate cancer, gastro-intestinal cancer, brain cancer and others. Currently, gastro-intestinal cancer segment occupies the highest proton therapy systems market share (nearly 30%). This can be attributed to the rising incidence gastro-intestinal cancer across the globe that underscore the demand for proton therapy systems to target cancerous cells. However, in the future, lung cancer segment is likely to register a higher CAGR driven by the expanding usage of proton therapy to target tumor cells in lungs.
Based on the end user, the global market is bifurcated into hospitals, proton therapy centers and other end users. Currently, the hospitals segment holds the maximum share (56%) of the proton therapy systems market and the trend of dominance is likely to remain unchanged during the forecast period. This dominance is due to the fact that hospital has dedicated oncologists and specialized multi-system rooms to delivery proton therapy under expert supervision. Additionally, the hospitals prefer to deliver patient-centered care is likely to be a key reason for highest share.
However, with growing patient preferences for personalized treatment, it is expected that proton therapy centers segment is likely to grow at a higher CAGR during the forecast period.
Proton therapy systems market analysis highlights the distribution of the market across various geographical regions, such as North America, Europe and Asia-Pacific, Middle East and North Africa and Latin America. According to our projections, presently North America is likely to hold the majority (38%) of the current market share, and this trend is likely to remain unchanged in the future. This dominance is likely to be the result of rising prevalence of non-small cell lung cancer and growing expenditure on advanced healthcare infrastructure to treat patients with different forms of cancer.
However, the market is Asia-Pacific, is likely to grow at a relatively higher CAGR during the forecast period. This lucrative growth is due to the increasing research on cancer and wide patient pool that necessitated the demand for advanced proton therapy systems for precise treatment. In 2025, a number of hospitals based in India have announced investments to install proton therapy systems. In addition to the investment made by Apollo Hospitals in March 2025, AIG group also announced investment of INR 800 crore (~USD 94 million) in January 2025. The growing investments for establishing specialized proton therapy centers in Asia-Pacific region is likely to fuel the demand in the future.
The “Proton Therapy Systems Market: Industry Trends and Global Forecasts, till 2035” market report features an extensive study of the current market landscape, market size, market share, market growth, market trends, market value, market forecast, market outlook, statistics, and future opportunities for proton therapy system manufacturers. The market research report lays emphasis on the proton therapy systems that are being developed. Key takeaways of the market report are briefly discussed below.
The current market landscape is witnessing the presence of a wide array of well-established and new entrants. Majority of the industrial players active in this domain are focusing on the development of advanced proton therapy systems with higher efficacy. Furthermore, several hospital organizations and industrial players are making considerable investment to introduce new proton therapy systems. For instance, in January 2025, India based Apollo Hospitals Enterprise announced an investment of INR 250 crore to establish Proteus One proton therapy system in Hyderabad with an aim of enhancing cancer treatment in India. It is worth mentioning that the growing investment in proton therapy systems for treating cancer is likely to fuel its demand in the future, making the market highly competitive in the future.
The market for proton therapy systems is positively influenced by the rising prevalence of cancer across the globe. Proton therapy helps to target tumors with higher accuracy without affecting healthier cells / tissues, which becomes a crucial reason for widespread adoption across oncologists to treat patients. Additionally, the growing demand for target specific treatment for precise targeting of cancer cells is likely to be a key driver for the market.
Furthermore, the rising shift towards targeted therapies leads to the development of more proton therapy centers, which further fueled the demand for proton therapy equipment and services in the future. In February 2024, University of Leeds launched a clinical trial to evaluate proton beam therapy for treatment of oligodendroglioma, a type of brain cancer. St. Jude Children’s Hospital is also evaluating the proton beam therapy in a phase II clinical trial in newly diagnosed medulloblastoma, a type of brain tumor common in children.
Proton therapy systems have become a crucial part of cancer treatment driven by its efficacy in targeting cancer cells. Despite growing usage, the market is witnessing several challenges that may impede market growth during the forecast period. Some of the potential challenges are high initial investment and stringent guidelines. Consequently, the requirement of skilled personnel and regular maintenance requirement further increases the operational cost of proton therapy systems, which create challenges for the market players. Additionally, stringent guidelines for the development and approval of proton therapy system may restrain market growth during the forecast period.
Despite challenges, the market is growing exponentially driven by the increasing technological advancements to enhance precision and efficiency of the proton therapy systems. It is worth noting that the market players are focusing on the development of advanced tech-based proton therapy systems, such as pencil beam scanning and intensity-modulated proton therapy that allow delivery of highly focused proton means across tumor site while sparing the health tissues.
Furthermore, the industrial players are integrating advanced imaging technologies, such as CT scans for high-resolution imaging of tumor boundaries to identify the target sites is further creating opportunities for market players to innovate advanced technologies.
The global market for proton therapy systems is valued at USD 1.66 billion and is projected to reach USD 4.09 billion by 2035, expecting a CAGR of 9.4% during the forecast period. Currently, the North America region accounts for the largest share in the market, driven by the increasing demand for advanced proton therapy systems to mitigate the concern of cancer.
Furthermore, several industrial players are leveraging partnerships to strengthen their product portfolio and enhance the adoption across healthcare industry. For instance, in August 2024, IBA announced that it has signed a Memorandum of Understanding agreement with University of Pennsylvania Health System for installing two Proteus®ONE (compact proton therapy solutions) to treat cancer patients at the Penn Presbyterian Medical Center in Philadelphia, PA, USA.
Examples of key players engaged in this domain (which have also been captured in this report) include Advanced Oncotherapy, Hitachi, IBA Worldwide, Mevion Medical Systems, Optivus Proton Therapy, ProTom International, ProNova Solutions, Sumitomo Heavy Industries and Varian Medical Systems. This market report includes an easily searchable excel database of all the companies focusing on the development of proton therapy systems.
The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:
Several recent developments have taken place in the field of proton therapy systems. We have outlined some of these recent initiatives below.